These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4727450)

  • 1. [Does magnesium-orotate improve the effect of lipid lowering drugs?].
    Irsigler K; Flegel U; Kühn P; Schubert H; Iván E; Biro L; Székely L
    Int J Clin Pharmacol; 1973 Aug; 8(1):85-95. PubMed ID: 4727450
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum-lipid reducing principles--possibilities for treatment. 5. Indications for nicotinic acid and nicotinic acid derivatives].
    Orö L
    Lakartidningen; 1970 Dec; 67():Suppl IV:63+. PubMed ID: 5511953
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of tocopherol nicotinate on serum lipids].
    Aigner O; Schlick W
    Int J Clin Pharmacol; 1974 Sep; 10(2):124-8. PubMed ID: 4448553
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic effect of Ciba 13437-Su in 40 patients with familial essential hyperlipemia].
    Schönbeck M; Forster G; Hirzel H; Jakab T; Rosenmund H
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1761-8. PubMed ID: 5451984
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of chlorfibrinic acid on the triglyceride and glycogen contents of human liver as well as on blood-level forming metabolites].
    Hanefeld M; Jaross W; Trübsbach A; Leonhardt W
    Z Gesamte Inn Med; 1972 Aug; 27(15):655-8. PubMed ID: 4629764
    [No Abstract]   [Full Text] [Related]  

  • 6. [Field study on the decrease of lipids using etofibrate].
    Schneider J; Haase W; Kaffarnik H
    Fortschr Med; 1976 May; 94(13):785-90. PubMed ID: 8362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H
    Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract]   [Full Text] [Related]  

  • 8. [The so-called risk factors in the diurnal profile and following acute alcohol intoxication].
    Hinz G; Pohl W
    Med Welt; 1976 Mar; 27(10):458-62. PubMed ID: 4690
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(3):407-15. PubMed ID: 4364073
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
    Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year trials with halofenate, clofibrate, and placebo.
    Dujovne CA; Azarnoff DL; Huffman DH; Pentikäinen P; Hurwitz A; Shoeman DW
    Clin Pharmacol Ther; 1976 Mar; 19(3):352-9. PubMed ID: 177242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)].
    von Löwis P; Klemens UH
    Dtsch Med Wochenschr; 1973 Dec; 98(49):2328-33. PubMed ID: 4357927
    [No Abstract]   [Full Text] [Related]  

  • 13. [Duplication of the left atrioventricular orifice (author's transl)].
    Mertz DP; Rusteborg J
    MMW Munch Med Wochenschr; 1975 Jan; 117(4):131-6. PubMed ID: 163431
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathophysiological study on lipoid metabolism in the liver under the influence of orotic acid and magnesium orotate].
    Szelenyi I; Pucsõk J; Nemesãnsky E; Sós J
    Arzneimittelforschung; 1971 Jun; 21(6):777-9. PubMed ID: 5109257
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biological disorders of alcoholic origin].
    Stoffels G; Pelc I; Brauman J; Verbanck M
    Acta Psychiatr Belg; 1975 Mar; 75(2):173-81. PubMed ID: 1233871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of triglyceridemia, lipemia, glycemia and weight index in patients with high and normal serum uric acid].
    Kuntz D; Rouques C; Paolaggi F; Ryckewaert A
    Pathol Biol (Paris); 1969 Apr; 17(7):399-403. PubMed ID: 4893908
    [No Abstract]   [Full Text] [Related]  

  • 17. [Assessment of health status and metabolic parameters of cosmonauts during space flight].
    Grigor'ev AI; Poliakov VV; Noskov VB; Kozharinov VI
    Kosm Biol Aviakosm Med; 1991; 25(6):48-9. PubMed ID: 8577167
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the problems of the consumption of alcohol in the brewing industry (author's transl)].
    Zober A; Bost HP; Weltle D
    Zentralbl Bakteriol B; 1979 Jun; 168(5-6):422-41. PubMed ID: 41383
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
    Sterner W; Schultz A
    Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term treatment of hyperlipidemic patients with clofibrate.
    Berkowitz D
    JAMA; 1971 Nov; 218(7):1002-5. PubMed ID: 5000568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.